Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

Autor: Alcaraz, Antonio, Castro-Díaz, David, Gacci, Mauro, Salonia, Andrea, Ficarra, Vincenzo, Carballido-Rodríguez, Joaquín, Rodríguez-Antolín, Alfredo, Medina-Polo, José, Fernández-Gómez, Jesús M, Cózar-Olmo, José M, Búcar-Terrades, Santiago, Pérez-León, Noemí, Brenes-Bermúdez, Francisco J, Molero-García, José M, Fernández-Pro-Ledesma, Antonio, Herdman, Michael, Angulo, Javier C, Manasanch, José, On Behalf Of The Qualiprost Study Group

Publikováno v: Journal of Clinical Medicine; Volume 11; Issue 13; Pages: 3615

The objective of this subset analysis was to evaluate and compare the efficacy and tolerability of two combination treatments for men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH). Data w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::642241c9e30b4305a95953860357b4c5

Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study

Autor: Antonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, David Castro-Díaz, Manuel Esteban-Fuertes, José Cózar-Olmo, Vincenzo Ficarra, Rafael Medina-López, Jesús Fernández-Gómez, Javier Angulo, José Medina-Polo, Francisco Brenes-Bermúdez, José Molero-García, Antonio Fernández-Pro-Ledesma, José Manasanch, on behalf of The QUALIPROST Study Group

Publikováno v: Journal of Clinical Medicine, Vol 9, Iss 2909, p 2909 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine
Volume 9
Issue 9
Digital.CSIC. Repositorio Institucional del CSIC
instname

To investigate whether tamsulosin (TAM) and the hexanic extract of Serenoa repens (HESr) are more effective in combination than as monotherapy in men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c538aecf3f320b53a72e76969861e810
https://www.mdpi.com/2077-0383/9/9/2909

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.